Kwon Tae-Eun, Chung Yoonsun, Lee Choonsik
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, United States of America.
Department of Nuclear Engineering, Hanyang University, Seoul, 04763, South Korea.
Nucl Eng Technol. 2024 Jul;56(7):2732-2739. doi: 10.1016/j.net.2024.02.034. Epub 2024 Feb 19.
This study developed internal dose coefficients for radioiodine, tailored to the Korean population, by incorporating the Korean biokinetic model along with the Korean S values. The observed differences in dose coefficients for Koreans compared to the International Commission on Radiological Protection (ICRP) reference values noticeably varied depending on physical half-lives of iodine isotopes. For longer-lived isotopes such as I-125 and I-129, significant differences in thyroid dose coefficients were observed, with ratios (Korean/ICRP) from 0.30 to 0.55, indicating that actual doses for Koreans can be considerably lower than those evaluated based on the ICRP data. However, for short-lived iodine isotopes, such as I-131, the thyroid dose coefficients were comparable to the ICRP reference values (ratio=0.95-0.98). These comparable dose coefficients resulted from the lower thyroidal iodine uptake in the Korean model being almost entirely offset by the higher thyroid self-absorption S values in the Korean phantoms. Additionally, this study delves into the substantial differences in absorbed dose coefficients for non-thyroidal regions and effective dose coefficients, which arose not only from physiological/anatomical variability but also technical differences in phantom design. The use of Korean-specific dose coefficients is advisable particularly in scenarios predicting elevated doses, yielding a more precise and clinically relevant dose assessment.
本研究通过纳入韩国生物动力学模型以及韩国的S值,开发了针对韩国人群的放射性碘内照射剂量系数。与国际放射防护委员会(ICRP)参考值相比,韩国人剂量系数的观察差异因碘同位素的物理半衰期而异。对于寿命较长的同位素,如I - 125和I - 129,甲状腺剂量系数存在显著差异,比率(韩国/ICRP)为0.30至0.55,这表明韩国人的实际剂量可能远低于基于ICRP数据评估的剂量。然而,对于短寿命碘同位素,如I - 131,甲状腺剂量系数与ICRP参考值相当(比率 = 0.95 - 0.98)。这些相当的剂量系数是由于韩国模型中较低的甲状腺碘摄取几乎完全被韩国体模中较高的甲状腺自吸收S值所抵消。此外,本研究深入探讨了非甲状腺区域吸收剂量系数和有效剂量系数的显著差异,这些差异不仅源于生理/解剖学变异性,还源于体模设计的技术差异。在预测剂量升高的情况下,尤其建议使用韩国特定的剂量系数,以进行更精确且与临床相关的剂量评估。